1. Home
  2. TVGN

as 05-21-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
.
-
-
%

Finance

Blank Checks

Nasdaq

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Founded: 2020 Country:
United States
United States
Employees: N/A City: WARREN
Market Cap: 128.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 1.0M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.44 EPS Growth: N/A
52 Week Low/High: $0.76 - $21.09 Next Earning Date: 05-28-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: